Latest stories on TNYA
Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript
Seeking Alpha56 · neutralgeneral
Tenaya Therapeutics granted RMAT designation from FDA for TN-401
The Fly67 · bullishgeneral
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire56 · neutralgeneral
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Business Insider56 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
Seeking Alpha55 · neutralgeneral
Tenaya Therapeutics GAAP EPS of -$0.20 misses by $0.13, revenue of $1.11M misses by $8.89M
Seeking Alpha28 · bearishearnings
Tenaya Therapeutics, Inc. (TNYA) files 8-K
SEC 8-K50 · neutralgeneral
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
StockTitan55 · neutralgeneral
Tenaya Therapeutics Ends Manufacturing Center Lease, Shifts Strategy
TipRanks48 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) files 8-K
SEC 8-K50 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) files 8-K
SEC 8-K50 · neutralgeneral
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer | TNYA Stock News
StockTitan56 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Seeking Alpha56 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
Seeking Alpha55 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM Transcript
Seeking Alpha59 · neutralproduct/pr
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM - Slideshow
Seeking Alpha55 · neutralproduct/pr
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 | TNYA Stock News
StockTitan56 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVC - Slideshow
Seeking Alpha50 · neutralgeneral
Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVC Transcript
Seeking Alpha56 · neutralproduct/pr
Tenaya Therapeutics, Inc. (TNYA) Presents at Heart Failure 2026 - Slideshow
Seeking Alpha50 · neutralgeneral